# Olive Medical Corp: Form D filings

Olive Medical Corp, a biotechnology company in Sandy, UT, filed 4 Form D notices with the SEC between 2009 and 2011. The latest, on November 28, 2011, reports $1 million sold of an offering with no set size to 17 investors.

Find out what Olive Medical Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Olive%20Medical%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Olive%20Medical%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Folive-medical-corp-1476058)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Olive%20Medical%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Olive%20Medical%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Folive-medical-corp-1476058)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Utah](https://specstream.ai/data/form-d/state/utah): 660 rows, by operating companies, filed since November 1, 2024, $33, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/utah
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 9690 SOUTH 300 WEST, SUITE 320 H, Sandy, UT, 84070
- Phone: (972) 740-2366
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Utah
- Year incorporated: 2009
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1476058

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 28, 2011 | New notice | Indefinite | $1,000,000 | Indefinite | 17 | Oct 18, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1476058/000147605811000001/0001476058-11-000001-index.htm) |
| Dec 10, 2010 | Amendment | $1,324,000 | $871,500 | $452,500 | 20 | Nov 5, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1476058/000147605810000005/0001476058-10-000005-index.htm) |
| Nov 17, 2010 | New notice | $1,324,000 | $488,500 | $835,500 | 13 | Nov 5, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1476058/000147605810000004/0001476058-10-000004-index.htm) |
| Nov 4, 2009 | New notice | $500,000 | $200,000 | $300,000 | 9 | Oct 21, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1476058/000147605809000001/0001476058-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| S. George Simon | Director |  |
| J. Michael Brown | Director |  |
| Curtis Wichern | Executive Officer |  |
| Laurant George Blanquart | Executive Officer |  |
| Jeremiah Henley | Executive Officer |  |
| Dann George Hughes | Director |  |
| Joshua Talbert | Executive Officer, Director |  |
| Donald Wichern | Executive Officer, Director |  |

## Other biotechnology companies in Utah that filed recently

- [Life Impact Partners 14 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-14-llc-2163022) offering · Nov 9, 2026
- [Life Impact Partners 15 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-15-llc-2163019) offering · Nov 9, 2026
- [Life Impact Partners 7 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-7-llc-2163024) offering · Nov 6, 2026
- [Life Impact Partners 6 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-6-llc-2163017) offering · Nov 6, 2026
- [Life Impact Partners 3 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-3-llc-2162995) offering · Nov 6, 2026
- [Life Impact Partners 5 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-5-llc-2162994) offering · Nov 6, 2026
- [Life Impact Partners 4 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-4-llc-2162993) offering · Nov 6, 2026
- [Life Impact Partners 2 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-2-llc-2162992) offering · Nov 6, 2026
- [Life Impact Partners 8 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-8-llc-2162973) offering · Nov 6, 2026
- [Life Impact Partners 1 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-1-llc-2154209) offering · Oct 22, 2026
- [3Helix, Inc.](https://specstream.ai/data/form-d/company/3helix-inc-2001622) $7.8 million · Sep 21, 2026
- [Halia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/halia-therapeutics-inc-1829255) $3.5 million · Aug 31, 2026
- [Paterna BioSciences HoldCo Inc.](https://specstream.ai/data/form-d/company/paterna-biosciences-holdco-inc-1989862) $6.3 million · Aug 12, 2026

[Every Form D from the week of Nov 28, 2011](https://specstream.ai/data/form-d/week/2011-11-28) · [All recent filings in Utah](https://specstream.ai/data/form-d/state/utah) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Olive Medical Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).